BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2018
View Archived Issues
Eli Lilly initiates phase I study of LY-3316531
Read More
Researchers discover new class of calcium-dependent antibiotics
Read More
FDA approves phase I/II study of ABTL-0812 in patients with advanced metastatic pancreatic cancer
Read More
BirchBioMed's topical kynurenic acid formulation is safe in healthy volunteers
Read More
FUJIFILM RI Pharma begins phase II studies of F-1641 for refractory pheochromocytoma in Japan
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery patent PTGDR2 antagonists
Read More
Roche discovers novel mGlu4 receptor positive allosteric modulators
Read More
ISA Pharmaceuticals, Scancell enter collaboration agreement to develop Modi-1
Read More
TP Therapeutics describes novel BTK/JAK2/NTRK1 inhibitors
Read More
Ki-67 and AZGP1 shown as predictors of prostate cancer metastasis and death
Read More
FDA grants orphan drug designation to siplizumab to prevent solid organ transplant rejection
Read More
Gene therapy for limb girdle muscular dystrophy type 2E granted FDA orphan title
Read More
Biomarker panel tied to mucosal healing in adalimumab-treated ulcerative colitis patients
Read More
Erdafitinib active in phase II study in urothelial carcinoma with FGFR alterations
Read More
Rabies vaccine YS-ON-001 named an FDA orphan drug for pancreatic cancer
Read More
Zealand Pharma and UniQuest begin venom-based collaboration for gastrointestinal diseases
Read More
Tessa Therapeutics patents GPC3-targeting CARs
Read More
Phase II development of LY-3337641 for rheumatoid arthritis ended
Read More
Researchers in Korea patent LRG1-containing fusion proteins
Read More
Disease control seen with pexastimogene devacirepvec in metastatic, refractory renal cell carcinoma
Read More
Veritas Pharma plans to take over remaining 20% of Cannevert
Read More
Kancera considers development of KAND-567 in cancer and cardiovascular disease
Read More
AbbVie and Voyager collaborate to develop vectorized antibodies against tau
Read More
PDL BioPharma will no longer pursue Neos Therapeutics
Read More
Minoryx spins off SEE-Tx platform into Gain Therapeutics
Read More
Tell us what you think about TRDN
Read More